Cargando…
The emerging role of histone lysine demethylases in prostate cancer
Early prostate cancer (PCa) is generally treatable and associated with good prognosis. After a variable time, PCa evolves into a highly metastatic and treatment-refractory disease: castration-resistant PCa (CRPC). Currently, few prognostic factors are available to predict the emergence of CRPC, and...
Autores principales: | Crea, Francesco, Sun, Lei, Mai, Antonello, Chiang, Yan Ting, Farrar, William L, Danesi, Romano, Helgason, Cheryl D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441810/ https://www.ncbi.nlm.nih.gov/pubmed/22867098 http://dx.doi.org/10.1186/1476-4598-11-52 |
Ejemplares similares
-
The role of histone lysine demethylases in cancer cells’ resistance to tyrosine kinase inhibitors
por: White, Jasmine Cassar, et al.
Publicado: (2019) -
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
por: Chianese, Ugo, et al.
Publicado: (2022) -
Histone lysine demethylases in Drosophila melanogaster
por: Holowatyj, Andreana, et al.
Publicado: (2015) -
Histone demethylase lysine demethylase 5B in development and cancer
por: Han, Mengjiao, et al.
Publicado: (2016) -
Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018)